These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1045 related items for PubMed ID: 27686563

  • 1. Neuroinflammatory component of gray matter pathology in multiple sclerosis.
    Herranz E, Giannì C, Louapre C, Treaba CA, Govindarajan ST, Ouellette R, Loggia ML, Sloane JA, Madigan N, Izquierdo-Garcia D, Ward N, Mangeat G, Granberg T, Klawiter EC, Catana C, Hooker JM, Taylor N, Ionete C, Kinkel RP, Mainero C.
    Ann Neurol; 2016 Nov; 80(5):776-790. PubMed ID: 27686563
    [Abstract] [Full Text] [Related]

  • 2. (11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas.
    Park E, Gallezot JD, Delgadillo A, Liu S, Planeta B, Lin SF, O'Connor KC, Lim K, Lee JY, Chastre A, Chen MK, Seneca N, Leppert D, Huang Y, Carson RE, Pelletier D.
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1081-92. PubMed ID: 25833352
    [Abstract] [Full Text] [Related]

  • 3. Characterization of cortico-meningeal translocator protein expression in multiple sclerosis.
    Herranz E, Treaba CA, Barletta VT, Mehndiratta A, Ouellette R, Sloane JA, Ionete C, Babu S, Mastantuono M, Magon S, Loggia ML, Makary MM, Hooker JM, Catana C, Kinkel RP, Nicholas R, Klawiter EC, Magliozzi R, Mainero C.
    Brain; 2024 Jul 05; 147(7):2566-2578. PubMed ID: 38289855
    [Abstract] [Full Text] [Related]

  • 4. Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.
    Datta G, Colasanti A, Rabiner EA, Gunn RN, Malik O, Ciccarelli O, Nicholas R, Van Vlierberghe E, Van Hecke W, Searle G, Santos-Ribeiro A, Matthews PM.
    Brain; 2017 Nov 01; 140(11):2927-2938. PubMed ID: 29053775
    [Abstract] [Full Text] [Related]

  • 5. A longitudinal study of cortical grey matter lesion subtypes in relapse-onset multiple sclerosis.
    Sethi V, Yousry T, Muhlert N, Tozer DJ, Altmann D, Ron M, Wheeler-Kingshott C, Miller DH, Chard DT.
    J Neurol Neurosurg Psychiatry; 2016 Jul 01; 87(7):750-3. PubMed ID: 26272028
    [Abstract] [Full Text] [Related]

  • 6. Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load : A 3-Tesla Magnetic Resonance Imaging Study.
    Al-Radaideh A, Athamneh I, Alabadi H, Hbahbih M.
    Clin Neuroradiol; 2019 Mar 01; 29(1):51-64. PubMed ID: 29299614
    [Abstract] [Full Text] [Related]

  • 7. 11C-PBR28 and 18F-PBR111 Detect White Matter Inflammatory Heterogeneity in Multiple Sclerosis.
    Datta G, Colasanti A, Kalk N, Owen D, Scott G, Rabiner EA, Gunn RN, Lingford-Hughes A, Malik O, Ciccarelli O, Nicholas R, Nei L, Battaglini M, De Stefano N, Matthews PM.
    J Nucl Med; 2017 Sep 01; 58(9):1477-1482. PubMed ID: 28302760
    [Abstract] [Full Text] [Related]

  • 8. The relationship between white matter fiber damage and gray matter perfusion in large-scale functionally defined networks in multiple sclerosis.
    Ma AY, Vitorino RC, Hojjat SP, Mulholland AD, Zhang L, Lee L, Carroll TJ, Cantrell CG, Figley CR, Aviv RI.
    Mult Scler; 2017 Dec 01; 23(14):1884-1892. PubMed ID: 28178867
    [Abstract] [Full Text] [Related]

  • 9. Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis.
    Hojjat SP, Kincal M, Vitorino R, Cantrell CG, Feinstein A, Zhang L, Lee L, O'Connor P, Carroll TJ, Aviv RI.
    AJNR Am J Neuroradiol; 2016 Aug 01; 37(8):1454-61. PubMed ID: 27012299
    [Abstract] [Full Text] [Related]

  • 10. Gray matter microglial activation in relapsing vs progressive MS: A [F-18]PBR06-PET study.
    Singhal T, O'Connor K, Dubey S, Pan H, Chu R, Hurwitz S, Cicero S, Tauhid S, Silbersweig D, Stern E, Kijewski M, DiCarli M, Weiner HL, Bakshi R.
    Neurol Neuroimmunol Neuroinflamm; 2019 Sep 01; 6(5):e587. PubMed ID: 31355321
    [Abstract] [Full Text] [Related]

  • 11. Profiles of cortical inflammation in multiple sclerosis by 11C-PBR28 MR-PET and 7 Tesla imaging.
    Herranz E, Louapre C, Treaba CA, Govindarajan ST, Ouellette R, Mangeat G, Loggia ML, Cohen-Adad J, Klawiter EC, Sloane JA, Mainero C.
    Mult Scler; 2020 Oct 01; 26(12):1497-1509. PubMed ID: 31368404
    [Abstract] [Full Text] [Related]

  • 12. DT MRI microstructural cortical lesion damage does not explain cognitive impairment in MS.
    Preziosa P, Pagani E, Morelli ME, Copetti M, Martinelli V, Pirro F, Falini A, Comi G, Filippi M, Rocca MA.
    Mult Scler; 2017 Dec 01; 23(14):1918-1928. PubMed ID: 28098510
    [Abstract] [Full Text] [Related]

  • 13. The role of global and regional gray matter volume decrease in multiple sclerosis.
    Grothe M, Lotze M, Langner S, Dressel A.
    J Neurol; 2016 Jun 01; 263(6):1137-45. PubMed ID: 27094570
    [Abstract] [Full Text] [Related]

  • 14. Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging.
    Bezukladova S, Tuisku J, Matilainen M, Vuorimaa A, Nylund M, Smith S, Sucksdorff M, Mohammadian M, Saunavaara V, Laaksonen S, Rokka J, Rinne JO, Rissanen E, Airas L.
    Neurol Neuroimmunol Neuroinflamm; 2020 May 01; 7(3):. PubMed ID: 32123046
    [Abstract] [Full Text] [Related]

  • 15. Longitudinal change in TSPO PET imaging in progressive multiple sclerosis.
    Kang Y, Pandya S, Zinger N, Michaelson N, Gauthier SA.
    Ann Clin Transl Neurol; 2021 Aug 01; 8(8):1755-1759. PubMed ID: 34310086
    [Abstract] [Full Text] [Related]

  • 16. Evidence of diffuse cerebellar neuroinflammation in multiple sclerosis by 11C-PBR28 MR-PET.
    Barletta VT, Herranz E, Treaba CA, Ouellette R, Mehndiratta A, Loggia ML, Klawiter EC, Ionete C, Jacob SA, Mainero C.
    Mult Scler; 2020 May 01; 26(6):668-678. PubMed ID: 30973800
    [Abstract] [Full Text] [Related]

  • 17. Metabolic counterparts of sodium accumulation in multiple sclerosis: A whole brain 23Na-MRI and fast 1H-MRSI study.
    Donadieu M, Le Fur Y, Maarouf A, Gherib S, Ridley B, Pini L, Rapacchi S, Confort-Gouny S, Guye M, Schad LR, Maudsley AA, Pelletier J, Audoin B, Zaaraoui W, Ranjeva JP.
    Mult Scler; 2019 Jan 01; 25(1):39-47. PubMed ID: 29064346
    [Abstract] [Full Text] [Related]

  • 18. In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand ¹¹C-PK11195.
    Rissanen E, Tuisku J, Rokka J, Paavilainen T, Parkkola R, Rinne JO, Airas L.
    J Nucl Med; 2014 Jun 01; 55(6):939-44. PubMed ID: 24711650
    [Abstract] [Full Text] [Related]

  • 19. TSPO PET with [18F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing-remitting multiple sclerosis.
    Unterrainer M, Mahler C, Vomacka L, Lindner S, Havla J, Brendel M, Böning G, Ertl-Wagner B, Kümpfel T, Milenkovic VM, Rupprecht R, Kerschensteiner M, Bartenstein P, Albert NL.
    Eur J Nucl Med Mol Imaging; 2018 Jul 01; 45(8):1423-1431. PubMed ID: 29523925
    [Abstract] [Full Text] [Related]

  • 20. Multiparameter MRI quantification of microstructural tissue alterations in multiple sclerosis.
    Lommers E, Simon J, Reuter G, Delrue G, Dive D, Degueldre C, Balteau E, Phillips C, Maquet P.
    Neuroimage Clin; 2019 Jul 01; 23():101879. PubMed ID: 31176293
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.